Tag: Hepatitis
Cost-Effectiveness of Immediate HCV Rx in Early Disease Analyzed
Rx tied to substantial
costs that may compel clinicians, patients to consider delaying treatment
Antiviral Tx Improves Survival in Sorafenib-Treated HBV-HCC
Antiviral therapy with nucleoside analogues linked to improved overall survival
Hepatitis B Screening Endorsed Pre-Immunosuppressive Tx
Antiviral tx recommended to prevent reactivation for those found to be hepatitis B surface antigen-positive
Hepatitis A Hospitalizations Down From 2002 to 2011
Increase in age of those hospitalized, and in percent of hospitalizations covered by Medicare
Many Patients With HCV ‘Lost’ in U.S. Health Care System
Patients lost at each stage, from screening to disease confirmation to care and treatment
